Hematology & Blood Disorders
Browse our collection of health resources and expert insights.
Medicine’s Top Earners Are Not the M.D.s: Wellness Oncology & Hematology: Oncologists
Hematology & Blood Disordershttp://www.nytimes.com/2014/05/18/sunday-review/doctors-salaries-are-not-the-big-cost.html?src=me&ref=general&_r...
May is Skin Cancer Awareness Month: Wellness Oncology & Hematology: Oncologists
Cancer Research & InnovationAs we prepare for our the annual cancer walk in Calabasas, I wanted to raise awareness about skin cancer. Skin cancer ha...
Lung Cancer Awareness Month: Wellness Oncology & Hematology: Oncologists
Cancer TreatmentsNovember is Lung Cancer Awareness Month. Lung Cancer Awareness Month was started in 1995, and highlights the struggles t...
Leukemia: Common Types, Symptoms & Treatment in Southern California: Wellness Oncology & Hematology: Oncologists
Cancer Research & InnovationLeukemia is the general name for all types of cancer which affect the blood and the bone marrow. When a person’s b...
“It sounds crazy, but cancer has made me a better chef.”: Wellness Oncology & Hematology: Oncologists
Cancer TreatmentsAs medical oncologists in West Hills and Tarzana, Dr. Shaye, Dr. Lashkari and I are often asked if we are aware of new a...
“I have sat with countless patients and families to discuss grim prognoses”: Wellness Oncology & Hematology: Oncologists
Hematology & Blood DisordersAlthough the practice of hematology is very fulfilling from a intellectual standpoint, I find that the practice of medic...
FDA approves Xalkori (Crizotinib): Wellness Oncology & Hematology: Oncologists
Cancer Research & InnovationAs part of our recognition of November being Lung Cancer Awareness Month, Dr Omid Shaye, Dr Ashkan Lashkari and I would ...
FDA approves Perjeta for neoadjuvant breast cancer treatment: Wellness Oncology & Hematology: Oncologists
Cancer TreatmentsOften times, our patients ask us if we, as oncologists in Tarzana and West Hills communities, keep abreast of the latest...
FDA approves Imbruvica (ibrutinib) to treat chronic lymphocytic leukemia: Wellness Oncology & Hematology: Oncologists
Cancer Research & InnovationIn keeping our patients informed of the latest developments, I wanted to share with you a late breaking development. We ...
FDA approves Gilotrif (afatanib) for treatment in late stage lung cancer: Wellness Oncology & Hematology: Oncologists
Cancer Research & InnovationOften times, our patients ask us if we, as hematologist/oncologists in Tarzana and West Hills communities, keep on top o...